Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series

BACKGROUND: Immune checkpoint inhibitors can result in overlap syndrome comprised of myasthenia gravis, myositis and myocarditis. However, the mortality predictors have not been clearly delineated. METHODS: We examined the characteristics of 11 patients diagnosed with overlap syndrome at Cleveland C...

Descripción completa

Detalles Bibliográficos
Autores principales: Longinow, Joshua, Zmaili, Mohammad, Skoza, Warren, Kondoleon, Nicholas, Marquardt, Robert, Calabrese, Cassandra, Funchain, Pauline, Moudgil, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939107/
https://www.ncbi.nlm.nih.gov/pubmed/36128926
http://dx.doi.org/10.1002/cam4.5050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939107/
https://www.ncbi.nlm.nih.gov/pubmed/36128926
http://dx.doi.org/10.1002/cam4.5050

Ejemplares similares